The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analyses of clinical and biologic determinants of melanoma bone metastasis (Mel-Bone).
 
Norhan Mohammed
No Relationships to Disclose
 
Zorica Radic
No Relationships to Disclose
 
Irineu Illa-Bochaca
No Relationships to Disclose
 
Paul Wojack
No Relationships to Disclose
 
Agrima Dutt
Stock and Other Ownership Interests - Esperion Therapeutics; Iovance Biotherapeutics; Moderna Therapeutics; Regeneron
 
Milad Ibrahim
No Relationships to Disclose
 
Shi Qiu
Employment - Abbott Laboratories (I)
Leadership - Abbott Laboratories (I)
Stock and Other Ownership Interests - Abbott Laboratories; Abbott Laboratories (I); Abbvie; Danaher; Iovance Biotherapeutics; Lilly; Merck; Novo Nordisk; Nucana; Summit Therapeutics
 
Dania Annuar
No Relationships to Disclose
 
Sooran Kim
No Relationships to Disclose
 
Yue Pan
No Relationships to Disclose
 
Onyekwere Onwumere
No Relationships to Disclose
 
George Jour
No Relationships to Disclose
 
Nicola Fabbri
No Relationships to Disclose
 
Ilya Laufer
Honoraria - AO Foundation
Consulting or Advisory Role - Icotec
Patents, Royalties, Other Intellectual Property - Globus
Travel, Accommodations, Expenses - AO Foundation
 
Anand Mahadevan
No Relationships to Disclose
 
Philipp Leucht
Consulting or Advisory Role - Stryker
Research Funding - Stryker
 
Abraham Chachoua
No Relationships to Disclose
 
Eva Hernando-Monge
No Relationships to Disclose
 
Huilin Li
No Relationships to Disclose
 
Iman Osman
Employment - Dracen (I)
Leadership - Dracen (I); Dracen (I)